105 related articles for article (PubMed ID: 2342974)
1. Intraperitoneal alpha interferon for ovarian cancer: a case report.
Carney-Gersten P; Moore MD; Giuffre M
Oncol Nurs Forum; 1990; 17(3):403-7. PubMed ID: 2342974
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal recombinant alpha 2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancer.
Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
Cancer Treat Rev; 1985 Dec; 12 Suppl B():23-32. PubMed ID: 3833327
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers].
Kasamatsu T; Ohmi K; Takeuchi S; Takamizawa H; Matsuzawa M; Kawana T; Ueda K; Kubo H; Tsumuji Y; Kawashima Y
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1656-60. PubMed ID: 3896157
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
[TBL] [Abstract][Full Text] [Related]
6. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
Freedman RS; Gutterman JU; Wharton JT; Rutledge FN
J Biol Response Mod; 1983; 2(2):133-8. PubMed ID: 6644331
[TBL] [Abstract][Full Text] [Related]
8. Recombinant leukocyte alpha interferon in advanced ovarian carcinoma.
Niloff JM; Knapp RC; Jones G; Schaetzl EM; Bast RC
Cancer Treat Rep; 1985; 69(7-8):895-6. PubMed ID: 4016797
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
Marin K; Oleszewski K; Muehlbauer P
Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
Sarna GP; Figlin RA
Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
[TBL] [Abstract][Full Text] [Related]
11. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Laszlo J
J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
[TBL] [Abstract][Full Text] [Related]
13. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
15. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of weekly high-dose human lymphoblastoid interferon.
Connors JM; Silver HK
Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
[TBL] [Abstract][Full Text] [Related]
18. Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
Sarna G; Figlin R; Callaghan M
J Biol Response Mod; 1983; 2(4):343-7. PubMed ID: 6315898
[TBL] [Abstract][Full Text] [Related]
19. Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.
Zeimet AG; Reimer D; Radl AC; Reinthaller A; Schauer C; Petru E; Concin N; Braun S; Marth C
Anticancer Res; 2009 Jul; 29(7):2803-8. PubMed ID: 19596965
[TBL] [Abstract][Full Text] [Related]
20. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
Anderson NJ; Hacker ED
Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]